Projects per year
Personal profile
Education
- 1983 MD, College of Medicine, National Taiwan University
Research Interests
- Cell Signaling Transduction
- Nanomedicine
- Oncology
- Clinical Trial
Experience
- 2004/08~now Professor, Department of Internal Medicine, College of Medicine, National Cheng Kung University
- 2017/08~now Director, Department of Internal Medicine, National Cheng Kung University Hospital
- 2004/07~now Chief, Division of Hematology/Oncology, Department of Internal Medicine, National Cheng Kung University Hospital
- 1990/08~now Attending Physician, National Cheng Kung University Hospital
- 2011/10~2017/07 Director, Cancer Center, National Cheng Kung University Hospital
- 2006/01~2011/09 Director, Clinical Trial Center, National Cheng Kung University Hospital
Fingerprint
Dive into the research topics where Wu-Chou Su is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Projects
Research output
-
Assessment of Serological Early Biomarker Candidates for Lung Adenocarcinoma by using Multiple Reaction Monitoring-Mass Spectrometry
Wu, H. Y., Pan, Y. Y., Kopylov, A. T., Zgoda, V., Ma, M. C., Wang, C. H., Su, W. C., Lai, W. W., Cheng, P. N. & Liao, P. C., 2020 Jul 1, In: Proteomics - Clinical Applications. 14, 4, 1900095.Research output: Contribution to journal › Article › peer-review
-
Clinical Frailty Scale in Predicting Postoperative Outcomes in Older Patients Undergoing Curative Surgery for Urologic Malignancies: A Prospective Observational Cohort Study
Sun, C. Y., Huang, C. C., Tsai, Y. S., Chang, Y. T., Ou, C. H., Su, W. C., Fan, S. Y., Wang, S. T., Yang, D. C., Huang, C. C. & Chang, C. M., 2020 Oct, In: Urology. 144, p. 38-45 8 p.Research output: Contribution to journal › Article › peer-review
-
Comparative effectiveness and costeffectiveness of three first-line EGFR-tyrosine kinase inhibitors: Analysis of real-world data in a tertiary hospital in Taiwan
Yang, S. C., Lai, W. W., Hsu, J. C., Su, W. C. & Wang, J. D., 2020 Apr, In: PloS one. 15, 4, e0231413.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Electric Field–Induced Release and Measurement (EFIRM): Characterization and Technical Validation of a Novel Liquid Biopsy Platform in Plasma and Saliva
Tu, M., Cheng, J., Chen, Y. L., Jea, W. C., Chen, W. L., Chen, C. J., Ho, C. L., Huang, W. L., Lin, C. C., Su, W. C., Ye, Q., Deignan, J., Grody, W., Li, F., Chia, D., Wei, F., Liao, W., Wong, D. T. W. & Strom, C. M., 2020 Aug, In: Journal of Molecular Diagnostics. 22, 8, p. 1050-1062 13 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLC
Nishio, M., Felip, E., Orlov, S., Park, K., Yu, C. J., Tsai, C. M., Cobo, M., McKeage, M., Su, W. C., Mok, T., Scagliotti, G. V., Spigel, D. R., Viraswami-Appanna, K., Chen, Z., Passos, V. Q. & Shaw, A. T., 2020 Apr, In: Journal of Thoracic Oncology. 15, 4, p. 609-617 9 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Citations (Scopus)